Related Experiment Video
Updated: Jan 12, 2026

Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
Congenital disorder of glycosylation type IIb in an infant with developmental and epileptic encephalopathy
R K Shwetabh1, Anita Singh2, Kausik Mandal3
1Neonatology, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India.
Insights
A rare congenital disorder of glycosylation (CDG) type IIb, caused by MOGS gene mutations, was identified in an infant with severe developmental delay and seizures. A mannose-based diet showed partial improvement, emphasizing early diagnosis for better outcomes.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Background:
- Congenital disorders of glycosylation (CDG) are a group of rare inherited metabolic diseases affecting protein and lipid glycosylation.
- CDG type IIb, specifically linked to MOGS gene mutations, presents with complex multisystemic symptoms, including neurological and developmental issues.
- Early diagnosis and intervention are crucial for managing CDG, but recognition can be challenging due to overlapping symptoms with other conditions.
Purpose of the Study:
- To report a case of a term infant with severe early-onset neurological and multisystemic symptoms.
- To identify the genetic cause of the infant's condition using whole exome sequencing.
- To evaluate the therapeutic effect of a mannose-based diet in managing the identified genetic disorder.
Main Methods:
- Clinical evaluation of a term infant presenting with progressive developmental delay, seizures, feeding difficulties, and failure to thrive.
- Comprehensive investigations including MRI, ruling out infections, metabolic acidosis, and structural brain malformations.
- Whole exome sequencing to identify the causative genetic mutation.
Main Results:
- The infant exhibited severe neonatal symptoms including vomiting, lethargy, seizures, neurological deterioration, hepatomegaly, nephromegaly, hypothyroidism, and auditory neuropathy.
- MRI revealed cerebral atrophy and dilated ventricles.
- Whole exome sequencing identified a homozygous missense mutation in the MOGS gene (c.2090T>C; p.Leu697Ser), confirming MOGS-CDG (CDG type IIb). A mannose-based diet resulted in partial clinical improvement.
Conclusions:
- This case underscores the importance of considering neurometabolic disorders like MOGS-CDG in infants with early-onset epileptic encephalopathy and multisystem involvement.
- Early genetic diagnosis through whole exome sequencing is critical for identifying MOGS-CDG.
- Supportive multidisciplinary care and potentially targeted dietary interventions, such as a mannose-based diet, can help improve outcomes and guide family counseling.
Abstract:
We report a term infant presenting in early infancy with progressive developmental delay, feeding difficulties, recurrent seizures and failure to thrive. The infant initially exhibited symptoms from early neonatal age, including vomiting, lethargy and seizures, necessitating multiple hospitalisations. Progressive neurological deterioration, hepatomegaly, bilateral nephromegaly, hypothyroidism, gastro-oesophageal reflux disease and auditory neuropathy were noted. MRI showed cerebral atrophy and dilated ventricles. Extensive investigations ruled out infections, metabolic acidosis and structural brain malformations. Whole exome sequencing identified a homozygous missense mutation in the mannosyl-oligosaccharide glucosidase (MOGS) gene (c.2090T>C; p.Leu697Ser), previously reported in MOGS CDG (congenital disorder of glycosylation type IIb). A mannose-based diet led to partial improvement. This case highlights the importance of considering neurometabolic conditions such as CDG in infants with early-onset developmental and epileptic encephalopathy and multisystem involvement. Early diagnosis and supportive multidisciplinary care are vital for improving outcomes and guiding family counselling.
More Related Videos
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
08:04Identification and Classification of Position-specific GABAA Receptor Subunit Missense Variants for Their Role In Hippocampal Pyramidal Neurons
Published on: June 6, 2025
Related Concept Videos
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Type 2 and Gestational